Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.54 USD | +0.45% | +6.94% | +26.13% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.13% | 4.05B | |
+25.90% | 42.68B | |
-3.90% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.67% | 24.94B | |
-21.62% | 18.96B | |
+27.75% | 12.3B | |
-2.96% | 11.95B | |
-1.88% | 11.55B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US